New drug ABBV-547 enters first human safety trial

NCT ID NCT07232004

Ongoing Knowledge-focused Sponsor: AbbVie Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jul 24, 2026 · Updated 2 times

Summary

This early-stage study tests a single dose of ABBV-547 in healthy adults to check its safety, how the body processes it, and any side effects. About 121 participants in the US and Japan will receive either the drug or a placebo. The study has two parts with different dosing groups.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: ABBV-547
What could go wrong: This is a very early Phase 1 trial in healthy volunteers, so it cannot show whether ABBV-547 works for any disease. The main goal is safety, not effectiveness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY VOLUNTEER

Contacts and locations

Show contact details

Locations

Acpru /Id# 278638

Grayslake, Illinois, 60030, United States
Advanced Clinical Research Institute - Tampa /ID# 279342

Tampa, Florida, 33607, United States
Austin Institute for Clinical Research - Pflugerville /ID# 279387

Pflugerville, Texas, 78660, United States
CenExel ACT- Anaheim Clinical Trials /ID# 279612

Anaheim, California, 92801, United States
Center for Clinical Studies - Houston - Binz Street /ID# 279419

Houston, Texas, 77004, United States
Dermatology Research Associates - Los Angeles /ID# 279383

Los Angeles, California, 90045, United States
Dermatology Trial Associates /ID# 279984

Bryant, Arkansas, 72022, United States
Equity Medical, LLC - Bronx /ID# 279808

The Bronx, New York, 10455, United States
Fukuoka University Hospital /ID# 279530

Fukuoka, 814-0180, Japan
Health Concepts /ID# 279529

Rapid City, South Dakota, 57702, United States
Integrative Skin Science and Research - Location 2 /ID# 279386

Sacramento, California, 95815, United States
MediSearch Clinical Trials /ID# 279416

Saint Joseph, Missouri, 64506, United States
MetroBoston Clinical Partners /ID# 279992

Boston, Massachusetts, 02135, United States
Minnesota Clinical Study Center /ID# 279987

New Brighton, Minnesota, 55112, United States
Oregon Dermatology and Research Center /ID# 279391

Portland, Oregon, 97210, United States
Skin Care Research Boca Raton /ID# 279988

Boca Raton, Florida, 33486-2269, United States
Skin Specialists /ID# 279531

Omaha, Nebraska, 68144, United States
The Skin Center Dermatology Group /ID# 279983

New City, New York, 10956-7153, United States
Total Dermatology /ID# 279798

Birmingham, Alabama, 35203-4024, United States
Trueblue Clinical Research - Tampa /ID# 281757

Tampa, Florida, 33609, United States
University Dermatology & Vein Clinic - Darien /ID# 279986

Darien, Illinois, 60561, United States
University of the Ryukyus Hospital /ID# 279918

Ginowan-shi, Okinawa, 901-2725, Japan
Wellness Clinical Research - Miami Lakes /ID# 279803

Miami Lakes, Florida, 33016, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.